Analysts See Upside for EUSA ETF and Key Holdings

Analysts are optimistic about the iShares MSCI USA Equal Weighted ETF (EUSA) with an implied target price indicating a potential upside of 9.72%. Notable stocks such as Centene Corp (CNC), Royalty Pharma plc (RPRX), and Agilent Technologies (A) show strong upside potentials exceeding 20%.

Date: 19-05-2025

AI Rating: 7

**Analyst Outlook for EUSA ETF and its Holdings**: The analysis provides a positive outlook, particularly for the iShares MSCI USA Equal Weighted ETF (EUSA). With a recent trading price of $97.77 and an implied analyst target of $107.27, this indicates a 9.72% potential upside over the next 12 months. The ETF's structure allows it to reflect the performance of its underlying holdings, which are notably optimistic.

Among its top holdings, Centene Corp (CNC) stands out with an average analyst target price of $76.87, representing a potential upside of 24.42% from its recent price of $61.78. Royalty Pharma plc (RPRX) follows closely with a target of $41.67, showing a 22.40% upside from $34.04. Agilent Technologies (A) is also highly regarded, with analysts seeing it reach $139.00, up by 22.18% from its current price of $113.77. Such significant potential returns indicate robust expectations from analysts.

However, given the average market volatility, it must be noted that these high projections could also lead to possible target price downgrades in the future if the companies do not meet their projected performance. For the EUSA ETF, the average investor should consider the underlying sector performance and overall market conditions before acting on these analyst opinions.

The strong upside potential for CNC, RPRX, and A could indicate favorable growth prospects, and investors may want to research each company further to assess whether the analyst targets are justified compared to company fundamentals.

Stocks: EUSA CNC RPRX A